India Inc's revenue growth will remain flat at about 5-6 per cent in the March quarter, but profitability will widen, a domestic rating agency said on Thursday. Crisil Ratings said the operating profit margins are seen at 8 per cent, a widening of up to 0.60 per cent, when compared with the year-ago performance. The agency analysed over 400 companies accounting for over 50 per cent of NSE's market capitalisation to arrive at its estimates. Some companies, especially in the information technology sector have already announced their earnings. Improved showing by the consumer-driven sectors excluding staples will be a key contributor for the topline growth, while the bottom line will benefit from a mixed set of aspects which are unique to a sector, it said. Crisil Intelligence's director Pushan Sharma said consumer discretionary products, services and staple services segment is expected to see 8-9 per cent on-year increase in revenue. "This would be led by an expected 15 per cent sur
SBI Life's net premium income fell about 5% to Rs 23,861 crore as single premiums dropped nearly 73% while first-year premiums rose about 7%
Drug firm Laurus Labs on Thursday said its consolidated profit increased three-fold to Rs 234 crore for the March quarter, driven by strong sales. The Hyderabad-based company reported a net profit of Rs 76 crore for the same quarter of FY24. Revenue increased to Rs 1,720 crore for the fourth quarter as compared with Rs 1,440 crore in the year-ago period, Laurus Labs said in a regulatory filing. For FY25, the company said its profit rose to Rs 358 crore as against Rs 161 crore in the 2023-24 fiscal year, it added. Revenue increased to Rs 5,554 crore in last fiscal year as compared with Rs 5,041 crore in the 2023-24 financial year. "We delivered very good Q4 results and continued our transformative progress, reflecting robust demand for our CDMO offerings and meeting complex customer needs," Laurus Labs Founder & CEO Satyanarayana Chava said. The company is deepening its cooperation with major clients, and augmenting it with promising BD and capacity creation, he added. "Our ...
Adani Energy Solutions Ltd (AESL) on Thursday reported an 87 per cent rise in consolidated net profit to Rs 713.66 crore in the March quarter, on higher income. It had posted a net profit of Rs 381.29 crore in the January-March period of preceding 2023-24 financial year, the company said in a regulatory filing. During the quarter, the company's total income surged to Rs 6,596.39 crore from Rs 4,855.18 crore in the same period a year ago. While expenses stood at Rs 5,411.60 crore against Rs 4,358.83 crore in the fourth quarter last fiscal. For the full FY25, AESL reported a net profit of Rs 921 crore, lower than Rs 1,195.61 crore in FY24. Total income rose to Rs 24,446.55 crore in the full fiscal, up from Rs 17,218.31 crore a year ago. AESL, part of Adani portfolio, is into power transmission, distribution, smart metering, and cooling solutions.
Its sales volumes rose 14% on-year, above the 5%-12% range estimated by at least three brokerages, and lifted overall revenue by 12% to 59.49 billion rupees
Sensex Today | Stock Market Close Highlights: Equity markets traded with a negative bias on Thursday in the aftermath of Kashmir terror attack, and some profit-taking following the 7-day rally.
Nestle India Ltd on Thursday reported 6.5 per cent decline in consolidated net profit at Rs 873.46 crore for March quarter FY25 as the FMCG industry faced food inflation and moderation in urban consumption. The company posted a profit of Rs 934.17 crore for the January-March period a year ago, according to a regulatory filing from Nestle India. Revenue from the sale of products was up at Rs 5,447.64 crore in the quarter as against Rs 5,254.43 crore a year ago. "Total sales and domestic sales for the quarter increased 3.7 per cent and 4.2 per cent, respectively. Domestic sales growth was broad-based. Domestic sales crossed Rs 5,235 crore, the highest ever, surpassing that of JanuaryMarch 2024 quarter," said Nestle India, which owns popular brands as Maggi, Nescafe and Kit Kat. However, exports were down 8.65 per cent to Rs 212.66 crore in Q4 FY25 due to commodity headwinds in coffee. In March quarter, total expenses of Nestle India were at Rs 4,307.76 crore. Revenue from operation
HUL, Nestle and Tata Consumer stocks are seen trading on a divergent note after reporting Q4 earnings; technical charts suggest these stocks can potentially rally up to 15% from present levels.
LTIMindtree shares today climbed 1 per cent in early deals to hit a high of ₹4,585 per share. They, however, gave up gains and hit a low of ₹4,450 per share in the intraday trade
HUL share price: The fast-moving consumer goods (FMCG) giant released its fourth quarter (Q4FY25) results on Thursday, during market hours.
Thyrocare Technologies share price: In Q4, the company's consolidated net profit including exceptional items stood at ₹21.3 crore as compared to ₹17.2 crore a year ago
The key focus during TVS Motor Company's Q4FY25 results, analysts believe, will be the e-mobility initiatives and demand outlook
Q4 FY25 company results today: SBI Life Insurance, Nelco, and SBI Cards and Payment Services will be among 37 companies to post earnings reports for the January-March quarter
HUL Q4 FY25 result: The company's board approved a final dividend of ₹24 per share, taking the full year payout to shareholders to ₹53 per share
Bajaj Housing Finance share price: Despite the double digit growth in net profit and revenue, most analysts have shared 'sell' side views on Bajaj Housing Finance stock
Tata Consumer share price: At 9:28 AM, Tata Consumer shares were trading 2.73 per cent lower at ₹1,119.45 per share on the BSE
Stock Market Today, Sensex Today, April 24: India's response to Pahalgam attack, Q4 results, and US President Donald Trump's trade deal with China are key factors that will guide stock markets today
HCLT is guiding for revenue growth in the range of 2-5 per cent for FY26, on consolidated basis and also its services
Bains further noted that after a subdued first half, impacted by a sector-wide downturn in US biotech funding, the second half of the year showed signs of recovery
Net sales in the reported quarter were up 17.3 per cent at ₹4,608 crore and its underlying volume growth for India branded business stood at 5.9 per cent (excluding acquisitions)